Bicalutamide 50 mg Film-Coated Tablets (Casodex) (Astrazeneca Pharmaceutical LP, USA)

DRUG2 trials

Sponsors

Sandoz

Conditions

HirsutismProstate Cancer

Phase 1

Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions

CompletedNCT00959335

SandozHirsutism, Prostate Cancer

Start: 2006-08-31End: 2006-08-31Updated: 2017-03-28

Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions

CompletedNCT00960310

SandozHirsutism, Prostate Cancer

Start: 2006-06-30End: 2006-06-30Updated: 2017-03-28